$58.50

+0.51 (+0.88%)

Weekly Expected Move ±6.4%

$50 $54 $58 $62 $65

NASDAQ · Healthcare · Medical - Healthcare Information Services · Alpha Radar Strong Buy · Power 74 · $11.3B mcap · 123M float · 2.42% daily turnover · Short 51% of daily vol

Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Dividends Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE

48.6 / 100

NoneWeakNarrowWide

Primary source: Cost Advantage · ROIC: 7.2%

Cost Advantage ★

Intangibles

Switching Cost

Network Effect

Scale

The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. BTSG shows a Weak competitive edge (48.6/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Cost Advantage. ROIC of 7.2% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets

$60

Low

$63

Avg Target

$70

High

Based on 8 analysts since May 1, 2026 earnings

Analyst Recommendations

Strong Buy: 0Buy: 12Hold: 0Sell: 0Strong Sell: 0

Rating Summary

ConsensusBuy

Avg Target$60.00

Analysts10

Price Target Change History

Date	Firm	Analyst	Old	New	Change	Upside @ Call	Stock@Call
2026-05-21	BMO Capital	—	$60	$70	+10	+18.3%	$59.16
2026-05-06	Morgan Stanley	—	$32	$62	+30	+18.2%	$52.44
2026-05-04	Deutsche Bank	—	$30	$60	+30	+12.1%	$53.51
2026-05-04	BTIG	—	$55	$65	+10	+23.6%	$52.58
2026-05-04	Stephens	—	$44	$64	+20	+21.7%	$52.58
2026-05-04	KeyBanc	—	$45	$60	+15	+14.1%	$52.58
2026-05-04	Wells Fargo	Stephen Baxter	$43	$61	+18	+16.0%	$52.58
2026-05-01	BMO Capital	—	$46	$60	+14	+14.1%	$52.58
2026-03-18	Leerink Partners	Whit Mayo	Initiated	$49	—	+11.8%	$43.82
2026-03-02	Cantor Fitzgerald	—	Initiated	$49	—	+20.5%	$40.65
2026-02-02	BTIG	David Larsen	$50	$55	+5	+40.1%	$39.27
2026-01-23	BMO Capital	—	Initiated	$46	—	+16.2%	$39.60
2026-01-09	Mizuho Securities	Ann Hynes	$42	$45	+3	+15.1%	$39.10
2026-01-07	Wells Fargo	—	$39	$43	+4	+5.7%	$40.67
2025-12-23	BTIG	—	$41	$50	+9	+31.6%	$38.00
2025-12-18	Mizuho Securities	—	$38	$42	+4	+18.0%	$35.58
2025-12-12	KeyBanc	Matthew Gillmor	Initiated	$45	—	+25.4%	$35.89
2025-12-10	Stephens	—	Initiated	$44	—	+24.9%	$35.23
2025-11-12	Wells Fargo	Stephen Baxter	$33	$39	+6	+15.0%	$33.91
2025-10-29	Mizuho Securities	Ann Hynes	$32	$38	+6	+10.2%	$34.47
2025-10-29	BTIG	David Larsen	Initiated	$41	—	+20.6%	$34.00
2025-10-29	UBS	—	Initiated	$42	—	+22.0%	$34.44
2025-10-21	Jefferies	Brian Tanquilut	Initiated	$36	—	+12.9%	$31.89
2025-10-17	Mizuho Securities	—	$26	$32	+6	+8.7%	$29.45
2025-10-14	Morgan Stanley	—	Initiated	$32	—	+10.9%	$28.85
2025-10-07	Wells Fargo	Stephen Baxter	Initiated	$33	—	+14.3%	$28.87
2025-09-08	Deutsche Bank	Pito Chickering	Initiated	$30	—	+17.7%	$25.48
2025-05-05	Mizuho Securities	Ann Hynes	Initiated	$26	—	+19.2%	$21.82

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

May 22, 2026

DCF

ROE

ROA

D/E

P/E

P/B

The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. BTSG receives an overall rating of B. Strongest factors: ROE (4/5), ROA (4/5). Areas of concern: D/E (1/5), P/E (2/5), P/B (2/5).

Rating Change History

Date	From	To
2026-05-20	B-	B
2026-05-12	B	B-
2026-05-12	B-	B
2026-05-04	B	B-
2026-05-01	B-	B
2026-04-22	B	B-
2026-04-01	B-	B
2026-02-27	C	B-
2026-01-03	C+	C

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 63 Grade B

Profitability

Balance Sheet

Earnings Quality

Growth

Value

Momentum

Safety

Cash Flow

The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. BTSG scores highest in Momentum (98/100) and lowest in Profitability (22/100). A grade of B indicates above-average fundamentals with room for improvement in select areas.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score

3.77

Safe Zone

Piotroski F-Score

8/9

✓ ✓ ✓ ✓ ✓ ✓ ✗ ✓ ✓

Beneish M-Score

-2.84

Unlikely Manipulator

Ohlson O-Score

-7.05

Bankruptcy prob: 0.1%

Low Risk

Credit Rating

BBB+

Score: 60.7/100

Trend: Improving

Earnings Quality

100/100

OCF/NI: 2.17x

Accruals: -4.5%

The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. BTSG scores 3.77, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. BTSG scores 8/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. BTSG's score of -2.84 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. BTSG's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. BTSG receives an estimated rating of BBB+ (score: 60.7/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). BTSG's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E

38.64x

PEG

0.09x

P/S

0.83x

P/B

6.05x

P/FCF

22.88x

P/OCF

18.44x

EV/EBITDA

21.12x

EV/Revenue

0.89x

EV/EBIT

29.31x

EV/FCF

29.57x

Earnings Yield

2.50%

FCF Yield

4.37%

Shareholder Yield

1.09%

Graham Number

$14.24

Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 38.6x earnings, BTSG commands a growth premium. Graham's intrinsic value formula yields $14.24 per share, 311% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden

1.112

NI / EBT

Interest Burden

0.509

EBT / EBIT

EBIT Margin

0.030

EBIT / Rev

Asset Turnover

2.212

Rev / Assets

Equity Multiplier

3.503

Assets / Equity

ROE

13.4%

The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. BTSG's ROE of 13.4% is driven by financial leverage (equity multiplier: 3.50x). Note: high leverage means ROE is amplified by debt rather than operational performance. A tax burden ratio of 1.11 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate

299.72%

Fair P/E

607.94x

Intrinsic Value

$647.06

Price/Value

0.07x

Margin of Safety

93.41%

Premium

-93.41%

Assessment

Undervalued

Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with BTSG's realized 299.7% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. At an intrinsic value of $647.06, BTSG appears undervalued with a 93% margin of safety. The adjusted fair P/E of 607.9x compares to the current market P/E of 38.6x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 583 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price

$58.50

Median 1Y

$109.77

5th Pctile

$52.76

95th Pctile

$228.58

Ann. Volatility

43.5%

Analyst Target

$60.00

25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

Executive	Salary	Stock	Total
Jon Rousseau President and Chief Executive Officer	$1,316,717	$6,000,015	$17,841,460
Jennifer Phipps Financial Vice President and Chief Financial Officer	$469,265	$1,500,004	$4,444,051
Lisa Nalley Staff of Staff and Senior Vice President, Human Resource	$349,680	$800,010	$2,396,266
Scott Greenwell President, Vice President and President, PharMerica	$249,041	$375,005	$1,436,755
Jennifer Yowler President, sident, PharMerica and Senior Vice President, Sales and Account Management	$440,003	$400,014	$1,351,531
Bob Barnes President, Community Living	$450,015	$—	$1,069,935
Jim Mattingly Financial ecutive Vice President and Chief Financial Officer	$106,154	$—	$543,457

CEO Pay Ratio

343:1

CEO-to-Employee Pay Ratio

CEO Total Comp: $17,841,460

Avg Employee Cost (SGA/emp): $52,022

Employees: 23,500

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees

23,500

-36.5% YoY

Revenue / Employee

$549,386

Rev: $12,910,564,000

Profit / Employee

$8,113

NI: $190,666,000

SGA / Employee

$52,022

Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability

Metric	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
ROE	-7.8%	-4.4%	-5.8%	-1.1%	5.1%	5.9%	11.6%	10.8%	13.4%	13.37%
ROA	-0.8%	-0.5%	-0.6%	-0.3%	1.0%	1.1%	2.3%	3.1%	3.8%	3.82%
ROIC	-0.3%	0.4%	1.5%	2.8%	4.1%	2.9%	4.5%	5.4%	7.2%	7.20%
ROCE	-0.7%	0.2%	1.6%	3.3%	5.0%	5.2%	5.9%	7.2%	9.1%	9.11%
Gross Margin	12.8%	12.8%	14.0%	13.8%	11.8%	11.9%	11.8%	11.6%	13.3%	13.34%
Operating Margin	-0.7%	1.6%	2.0%	2.6%	1.8%	1.5%	2.6%	4.0%	3.8%	3.81%
Net Margin	-2.0%	0.8%	-0.3%	0.5%	1.0%	0.9%	1.7%	2.2%	2.1%	2.06%
EBITDA Margin	0.9%	3.6%	3.7%	4.4%	3.2%	2.9%	3.9%	5.1%	4.9%	4.89%
FCF Margin	-4.4%	-3.0%	-1.7%	-0.5%	1.1%	1.6%	2.2%	3.1%	3.0%	3.02%
OCF Margin	-3.5%	-2.0%	-0.9%	0.2%	1.8%	2.2%	2.8%	3.8%	3.7%	3.75%
ROE 3Y Avg	snapshot only									2.74%
ROA 3Y Avg	snapshot only									1.27%
ROIC 3Y Avg	snapshot only									2.38%
ROIC Economic	snapshot only									7.20%
Cash ROA	snapshot only									7.98%
Cash ROIC	snapshot only									11.05%
CROIC	snapshot only									8.90%
NOPAT Margin	snapshot only									2.44%
Pretax Margin	snapshot only									1.55%
R&D / Revenue	snapshot only									0.00%
SGA / Revenue	snapshot only									9.13%
SBC / Revenue	snapshot only									0.43%

Valuation

Metric	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
P/E Ratio	-41.71	-91.91	-85.55	-200.98	67.94	77.89	49.72	42.90	40.03	38.645
P/S Ratio	0.83	0.50	0.38	0.34	0.34	0.43	0.52	0.63	0.69	0.831
P/B Ratio	3.26	4.06	4.98	2.20	2.36	3.10	3.91	4.36	5.03	6.050
P/FCF	-18.95	-17.00	-22.00	-63.53	30.49	26.70	23.34	20.72	22.88	22.883
P/OCF	—	—	—	152.69	19.04	19.00	18.45	16.69	18.44	18.436
EV/EBITDA	266.79	55.04	30.28	18.45	15.91	18.71	20.83	22.17	21.12	21.118
EV/Revenue	2.43	1.28	0.86	0.61	0.60	0.66	0.75	0.85	0.89	0.893
EV/EBIT	-198.34	569.45	97.45	44.19	29.88	33.79	34.89	33.24	29.31	29.307
EV/FCF	-55.28	-43.19	-49.62	-113.30	52.80	41.58	33.64	27.70	29.57	29.566
Earnings Yield	-2.4%	-1.1%	-1.2%	-0.5%	1.5%	1.3%	2.0%	2.3%	2.5%	2.50%
FCF Yield	-5.3%	-5.9%	-4.5%	-1.6%	3.3%	3.7%	4.3%	4.8%	4.4%	4.37%
PEG Ratio	snapshot only									0.091
EV/OCF	snapshot only									23.821
EV/Gross Profit	snapshot only									7.333
Acquirers Multiple	snapshot only									29.307
Shareholder Yield	snapshot only									1.09%
Graham Number	snapshot only									$14.24

Leverage & Solvency

Metric	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Current Ratio	1.17	1.17	1.17	1.33	1.33	1.33	1.33	1.57	1.57	1.565
Quick Ratio	0.84	0.84	0.84	0.88	0.88	0.88	0.88	1.12	1.12	1.124
Debt/Equity	6.28	6.28	6.28	1.76	1.76	1.76	1.76	1.52	1.52	1.516
Net Debt/Equity	6.25	6.25	6.25	1.73	1.73	1.73	1.73	1.47	1.47	1.469
Debt/Assets	0.66	0.66	0.66	0.49	0.49	0.49	0.49	0.44	0.44	0.443
Debt/EBITDA	175.95	33.50	16.91	8.28	6.87	6.84	6.52	5.76	4.93	4.927
Net Debt/EBITDA	175.33	33.38	16.85	8.10	6.72	6.70	6.38	5.58	4.77	4.774
Interest Coverage	-0.52	0.11	0.44	0.70	1.15	1.23	1.53	2.09	2.70	2.697
Equity Multiplier	9.46	9.46	9.46	3.60	3.60	3.60	3.60	3.42	3.42	3.420
Cash Ratio	snapshot only									0.048
Debt Service Coverage	snapshot only									3.743
Cash to Debt	snapshot only									0.031
FCF to Debt	snapshot only									0.145
Defensive Interval	snapshot only									315.8 days

Efficiency & Turnover

Metric	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Asset Turnover	0.41	0.85	1.38	1.80	1.97	2.09	2.17	2.09	2.21	2.212
Inventory Turnover	4.95	10.23	16.43	14.44	18.78	20.02	20.87	15.65	16.47	16.465
Receivables Turnover	2.59	5.36	8.66	10.39	11.81	12.55	13.00	12.79	13.52	13.522
Payables Turnover	3.11	6.42	10.31	9.83	12.38	13.19	13.75	10.55	11.10	11.101
DSO	141	68	42	35	31	29	28	29	27	27.0 days
DIO	74	36	22	25	19	18	17	23	22	22.2 days
DPO	117	57	35	37	29	28	27	35	33	32.9 days
Cash Conversion Cycle	97	47	29	23	21	20	19	17	16	16.3 days
Fixed Asset Turnover	snapshot only									36.262
Operating Cycle	snapshot only									49.2 days
Cash Velocity	snapshot only									154.421
Capital Intensity	snapshot only									0.470

Growth (YoY)

Metric	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Revenue	—	—	—	—	3.9%	1.5%	62.7%	20.8%	21.0%	21.02%
Net Income	—	—	—	—	2.3%	3.5%	4.8%	11.6%	3.1%	3.12%
EPS	—	—	—	—	2.0%	3.5%	4.5%	11.3%	3.0%	3.00%
FCF	—	—	—	—	2.3%	2.4%	3.1%	7.9%	2.2%	2.23%
EBITDA	—	—	—	—	19.3%	2.9%	1.1%	40.5%	36.4%	36.40%
Op. Income	—	—	—	—	15.7%	9.1%	2.3%	1.1%	84.6%	84.55%
OCF Growth	snapshot only									1.50%
Asset Growth	snapshot only									8.22%
Equity Growth	snapshot only									13.79%
Debt Growth	snapshot only									-2.14%
Shares Change	snapshot only									2.97%

Growth Quality

Metric	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Revenue Stability	—	—	—	—	—	—	—	—	0.90	0.898
Earnings Stability	—	—	—	—	—	—	—	—	0.98	0.977
Margin Stability	—	—	—	—	—	—	—	—	0.96	0.962
Rev. Growth Consistency	0.00	0.00	0.00	0.00	0.50	0.50	0.50	0.50	1.00	1.000
Earn. Growth Consistency	0.00	0.00	0.00	0.00	0.50	0.50	0.50	0.50	1.00	1.000
FCF Positive Streak	0	0	0	0	0	0	0	0	1	0
Earnings Persistence	—	—	—	—	—	—	—	—	0.50	0.500
Earnings Smoothness	—	—	—	—	—	—	—	—	0.00	0.000
ROE Trend	—	—	—	—	—	—	—	—	0.15	0.147
Gross Margin Trend	—	—	—	—	—	—	—	—	-0.01	-0.008
FCF Margin Trend	—	—	—	—	—	—	—	—	0.05	0.047
Sustainable Growth Rate	—	—	—	—	5.1%	5.9%	11.6%	10.8%	13.4%	13.37%
Internal Growth Rate	—	—	—	—	1.0%	1.2%	2.3%	3.2%	4.0%	3.97%

Cash Flow Quality

Metric	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
OCF/Net Income	1.72	3.64	1.96	-1.32	3.57	4.10	2.69	2.57	2.17	2.171
FCF/OCF	1.28	1.48	1.98	-2.40	0.62	0.71	0.79	0.81	0.81	0.806
FCF/Net Income	snapshot only									1.749
OCF/EBITDA	snapshot only									0.887
CapEx/Revenue	1.0%	1.0%	0.9%	0.8%	0.7%	0.6%	0.6%	0.7%	0.7%	0.73%
CapEx/Depreciation	snapshot only									0.617
Accruals Ratio	0.01	0.01	0.01	-0.01	-0.03	-0.04	-0.04	-0.05	-0.04	-0.045
Sloan Accruals	snapshot only									0.068
Cash Flow Adequacy	snapshot only									5.146
Earnings Quality Score	snapshot only									1.000

Dividends & Buybacks

Metric	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Dividend Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Dividend/Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Payout Ratio	—	—	—	—	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
FCF Payout Ratio	—	—	—	—	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Total Payout Ratio	—	—	—	—	0.6%	0.0%	0.0%	22.6%	43.8%	43.80%
Div. Increase Streak	—	—	—	—	—	—	—	—	—	—
Chowder Number	—	—	—	—	—	—	—	—	—	—
Buyback Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.5%	1.1%	1.09%
Net Buyback Yield	-54.8%	-44.0%	-35.9%	-28.8%	0.0%	0.0%	0.0%	0.4%	0.9%	0.85%
Total Shareholder Return	-54.8%	-44.0%	-35.9%	-28.8%	0.0%	0.0%	0.0%	0.4%	0.9%	0.85%

DuPont Factors

Metric	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Tax Burden (NI/EBT)	0.55	0.30	0.39	0.29	1.95	1.50	1.40	1.38	1.11	1.112
Interest Burden (EBT/EBIT)	2.94	-8.23	-1.28	-0.42	0.13	0.19	0.35	0.42	0.51	0.509
EBIT Margin	-0.01	0.00	0.01	0.01	0.02	0.02	0.02	0.03	0.03	0.030
Asset Turnover	0.41	0.85	1.38	1.80	1.97	2.09	2.17	2.09	2.21	2.212
Equity Multiplier	9.46	9.46	9.46	3.60	5.13	5.13	5.13	3.50	3.50	3.503

Per Share

Metric	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
EPS (Diluted TTM)	$-0.26	$-0.12	$-0.17	$-0.08	$0.27	$0.30	$0.59	$0.87	$1.06	$1.06
Book Value/Share	$3.33	$2.80	$2.95	$7.73	$7.67	$7.62	$7.56	$8.58	$8.47	$9.72
Tangible Book/Share	$-16.55	$-13.90	$-14.64	$-8.61	$-8.54	$-8.48	$-8.42	$-5.62	$-5.55	$-5.55
Revenue/Share	$13.02	$22.60	$38.44	$50.12	$52.46	$55.40	$56.94	$59.11	$61.66	$66.66
FCF/Share	$-0.57	$-0.67	$-0.67	$-0.27	$0.59	$0.88	$1.27	$1.81	$1.86	$2.01
OCF/Share	$-0.45	$-0.45	$-0.34	$0.11	$0.95	$1.24	$1.60	$2.24	$2.31	$2.50
Cash/Share	$0.07	$0.06	$0.07	$0.29	$0.28	$0.28	$0.28	$0.40	$0.40	$4.34
EBITDA/Share	$0.12	$0.52	$1.09	$1.65	$1.97	$1.96	$2.05	$2.26	$2.61	$2.61
Debt/Share	$20.91	$17.56	$18.49	$13.63	$13.52	$13.43	$13.33	$13.01	$12.84	$12.84
Net Debt/Share	$20.84	$17.50	$18.43	$13.34	$13.23	$13.14	$13.05	$12.61	$12.44	$12.44

Academic Models

Metric	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Altman Z-Score	—	—	—	—	—	—	—	—	—	3.771
Altman Z-Prime	snapshot only									3.654
Piotroski F-Score	1	1	1	3	7	7	7	7	8	8
Beneish M-Score	—	—	—	—	-2.37	-2.45	-2.39	-2.68	-2.84	-2.844
Ohlson O-Score	snapshot only									-7.050
Net-Net WC	snapshot only									$-7.38
EVA	snapshot only									$-129490571.47

Credit

Metric	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Credit Rating	snapshot only									BBB+
Credit Score	10.45	12.21	19.35	30.91	40.06	40.59	47.89	57.30	60.66	60.659
Credit Grade	snapshot only									8
Credit Trend	snapshot only									20.595
Implied Spread (bps)	snapshot only									225.000
Industry Credit Rank	snapshot only									55
Sector Credit Rank	snapshot only									53

BTSG NASDAQ

Edge Score

Analyst Insights

Financial Rating

InsiderStreet Scorecard

Risk & Quality Signals

Valuation

DuPont Decomposition (5-Factor)

Graham-Dodd Adjusted Valuation

Profitability Trends

Leverage & Solvency Trends

Efficiency & Working Capital Trends

Growth Trends (YoY %)

Earnings Stability

Monte Carlo Price Simulation

Executive Compensation

C-Suite Compensation

CEO Pay Ratio

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Scaling Efficiency

Sign in to InsiderStreet